- Expands Sanofi's presence in specialty care and strengthens leadership in rare diseases- Adds leader in the growing hemophilia market and provides platform for expansion in other rare blood disorders- Drives meaningful shareholder value with ROIC expected to exceed cost of capital within three years- Enhances Sanofi's sustainable revenue and...